🔎 Trials Near Me

Hjem › Overvekt › Texas › Dallas

Kliniske studier for Overvekt i Dallas, TX

20 studier for Overvekt søker deltakere på steder i og rundt Dallas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RekruttererFase 3
  • UT Southwestern Med Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekruttererFase 3
  • North Texas Endocrine Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • UT Southwestern Med Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

RekruttererFase 3
  • Cedar Health Research - Texas Native Health, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07794579

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RekruttererFase 3
  • UT Southwestern Medical Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • og 2 flere
Alder 45 til 99 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • FutureSearch Trials of Dallas, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

RekruttererFase 3
  • Cedar Health Research, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 til 75 · Alle kjønn · Oppdatert 8. sep. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Cedar Health Research, LLC, Dallas
Alder 18 til 99 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07684235

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

RekruttererFase 3
  • Mercy Family Clinic, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07509307

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Rekrutterer
  • University of Texas Southwestern, Children's Health, Dallas
Alder 6 til 14 · Alle kjønn · Oppdatert 30. mar. 2026 · NCT07342855

Healthy Living BEYOND Weight Study

RekruttererObservasjonsstudie
  • American Heart Association, Dallas
Alder 18 og eldre · Alle kjønn · Oppdatert 6. aug. 2025 · NCT07075341

Overvekt-studier i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.